Edwards Lifesciences | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Abbott USD 6.03B 93M 2024-12
AtriCure USD 92.62M 5.83M 2024-12
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Boston Scientific USD 3.1B 194M 2024-12
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Globus Medical USD 393.86M 38.67M 2024-12
Hologic USD 580.5M 22.8M 2024-12
ICU Medical USD 227.26M 22.41M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
J&J USD 15.41B 102M 2024-12
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.98M 15.45M 2024-12
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 157.45M 32.8M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Edwards Lifesciences سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.